What is the address of DEFFONTAINE BIOLOGIE CLINIQUE?

The registered office of DEFFONTAINE BIOLOGIE CLINIQUE is located at Pelgrimsstraat 108, 7700 Mouscron.

Is DEFFONTAINE BIOLOGIE CLINIQUE still active?

Yes. According to the CBE (28 September 2026) DEFFONTAINE BIOLOGIE CLINIQUE is active, legal situation “Normale toestand”, started on 18 January 2018.

Is DEFFONTAINE BIOLOGIE CLINIQUE registered on Peppol?

Yes, DEFFONTAINE BIOLOGIE CLINIQUE is registered on the Peppol network with ID 0208:0688592112.

What is the enterprise number of DEFFONTAINE BIOLOGIE CLINIQUE?

The enterprise number of DEFFONTAINE BIOLOGIE CLINIQUE is BE0688592112.

When was DEFFONTAINE BIOLOGIE CLINIQUE founded?

DEFFONTAINE BIOLOGIE CLINIQUE was founded on 18 January 2018.

Who are the directors of DEFFONTAINE BIOLOGIE CLINIQUE?

According to the 2025 annual accounts, the directors of DEFFONTAINE BIOLOGIE CLINIQUE are: Marine DEFFONTAINE.

Is DEFFONTAINE BIOLOGIE CLINIQUE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 January 2018; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DEFFONTAINE BIOLOGIE CLINIQUE make in 2025?

DEFFONTAINE BIOLOGIE CLINIQUE posted a profit after taxes of € 398,788 in financial year 2025.

What is the revenue of DEFFONTAINE BIOLOGIE CLINIQUE?

As a small company, DEFFONTAINE BIOLOGIE CLINIQUE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 634,796.

DEFFONTAINE BIOLOGIE CLINIQUE (Private Limited)

Dossier DEFFONTAINE BIOLOGIE CLINIQUE, printed on 28 September 2026 from databakkes.be/en/0688592112/deffontaine-biologie-clinique. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 13 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

DEFFONTAINE BIOLOGIE CLINIQUE from Mouscron, company number BE0688592112, closed financial year 2025 with a result of € 398,788 after tax. For that financial year DEFFONTAINE BIOLOGIE CLINIQUE recorded a gross margin of € 634,796 and equity of € 18,550. Compared with financial year 2024, the result moved from € 487,224 to € 398,788. The company is profitable. The buffer shrank hard: equity is 73 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 6, 2026.

What it is worth Shrank hard

€ 18,550

▼ 73% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 398,788

▼ 18% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 108,645

▲ 199% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 448,788 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 28,669

▼ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.4 million

▼ 1% vs 2024

€ 173,118 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 20

▼ 98% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 84,558

▲ 11% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 584,931 Gross margin 2022: € 584,931 First fiscal year in the series	€ 557,066 Gross margin 2023: € 557,066 ▼ 5% vs 2022 (€ 584,931) Unfavourable step	€ 670,594 Gross margin 2024: € 670,594 ▲ 20% vs 2023 (€ 557,066) Favourable step	€ 634,796 Gross margin 2025: € 634,796 ▼ 5% vs 2024 (€ 670,594) Unfavourable step	▼ 5%
Profit after taxes	€ 273,050 Profit after taxes 2022: € 273,050 First fiscal year in the series	€ 269,461 Profit after taxes 2023: € 269,461 ▼ 1% vs 2022 (€ 273,050) Unfavourable step	€ 487,224 Profit after taxes 2024: € 487,224 ▲ 81% vs 2023 (€ 269,461) Favourable step	€ 398,788 Profit after taxes 2025: € 398,788 ▼ 18% vs 2024 (€ 487,224) Unfavourable step	▼ 18%
Equity	€ 125,350 Equity 2022: € 125,350 First fiscal year in the series	€ 18,550 Equity 2023: € 18,550 ▼ 85% vs 2022 (€ 125,350) Unfavourable step	€ 68,550 Equity 2024: € 68,550 ▲ 270% vs 2023 (€ 18,550) Favourable step	€ 18,550 Equity 2025: € 18,550 ▼ 73% vs 2024 (€ 68,550) Unfavourable step	▼ 73%
Total debts	€ 2,658,764 Total debts 2022: € 2,658,764 First fiscal year in the series	€ 2,693,552 Total debts 2023: € 2,693,552 ▲ 1% vs 2022 (€ 2,658,764) Unfavourable step	€ 1,948,835 Total debts 2024: € 1,948,835 ▼ 28% vs 2023 (€ 2,693,552) Favourable step	€ 2,016,570 Total debts 2025: € 2,016,570 ▲ 3% vs 2024 (€ 1,948,835) Unfavourable step	▲ 3%
Cash	€ 152,575 Cash 2022: € 152,575 First fiscal year in the series	€ 31,453 Cash 2023: € 31,453 ▼ 79% vs 2022 (€ 152,575) Unfavourable step	€ 36,289 Cash 2024: € 36,289 ▲ 15% vs 2023 (€ 31,453) Favourable step	€ 108,645 Cash 2025: € 108,645 ▲ 199% vs 2024 (€ 36,289) Favourable step	▲ 199%
Land & buildings	€ 1,471,909 Land & buildings 2022: € 1,471,909 First fiscal year in the series	€ 1,934,115 Land & buildings 2023: € 1,934,115 ▲ 31% vs 2022 (€ 1,471,909) Unchanged	€ 1,884,855 Land & buildings 2024: € 1,884,855 ▼ 3% vs 2023 (€ 1,934,115) Unchanged	€ 1,833,387 Land & buildings 2025: € 1,833,387 ▼ 3% vs 2024 (€ 1,884,855) Unchanged	▼ 3%
Retained profit	€ 122,850 Retained profit 2022: € 122,850 First fiscal year in the series	€ 16,050 Retained profit 2023: € 16,050 ▼ 87% vs 2022 (€ 122,850) Unfavourable step	€ 66,050 Retained profit 2024: € 66,050 ▲ € 50,000 vs 2023 (€ 16,050) Favourable step	€ 16,050 Retained profit 2025: € 16,050 ▼ 76% vs 2024 (€ 66,050) Unfavourable step	▼ 76%
Dividend	€ 992,527 Dividend 2022: € 992,527 First fiscal year in the series	€ 376,261 Dividend 2023: € 376,261 ▼ 62% vs 2022 (€ 992,527) Unchanged	€ 437,224 Dividend 2024: € 437,224 ▲ 16% vs 2023 (€ 376,261) Unchanged	€ 448,788 Dividend 2025: € 448,788 ▲ 3% vs 2024 (€ 437,224) Unchanged	▲ 3%
Bank debt	€ 1,106,290 Bank debt 2022: € 1,106,290 First fiscal year in the series	€ 1,482,788 Bank debt 2023: € 1,482,788 ▲ 34% vs 2022 (€ 1,106,290) Unfavourable step	€ 1,370,993 Bank debt 2024: € 1,370,993 ▼ 8% vs 2023 (€ 1,482,788) Favourable step	€ 1,361,224 Bank debt 2025: € 1,361,224 ▼ 1% vs 2024 (€ 1,370,993) Favourable step	▼ 1%
Balance sheet total	€ 2,784,114 Balance sheet total 2022: € 2,784,114 First fiscal year in the series	€ 2,712,102 Balance sheet total 2023: € 2,712,102 ▼ 3% vs 2022 (€ 2,784,114) Unchanged	€ 2,017,385 Balance sheet total 2024: € 2,017,385 ▼ 26% vs 2023 (€ 2,712,102) Unchanged	€ 2,035,120 Balance sheet total 2025: € 2,035,120 ▲ 1% vs 2024 (€ 2,017,385) Unchanged	▲ 1%

Key figures of DEFFONTAINE BIOLOGIE CLINIQUE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DEFFONTAINE BIOLOGIE CLINIQUE?

What happened at DEFFONTAINE BIOLOGIE CLINIQUE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 6, 2026 New annual accounts for financial year 2025: profit of € 398,788 (▼ 18% vs 2024). Source: NBB ↗
Jan 18, 2018 New establishment in Mouscron. KBO
2018 Marine DEFFONTAINE became a director. NBB
Jan 18, 2018 Start of the company according to the CBE. KBO

In short

From € 273,050 profit in 2022 to € 398,788 profit in 2025.

Paid € 450,927 in corporate taxes since 2022.

Best year ever: 2024, with € 487,224 profit.

Paid out € 2.3 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DEFFONTAINE BIOLOGIE CLINIQUE? We notify you, reason included.

Follow DEFFONTAINE BIOLOGIE CLINIQUE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Marine DEFFONTAINE

DEFFONTAINE BIOLOGIE CLINIQUE

Behind DEFFONTAINE BIOLOGIE CLINIQUE is Marine DEFFONTAINE.

See the full network in the app

Directors

According to the 2025 annual accounts

Marine DEFFONTAINE

Director

since 2018

Establishments

Establishment units

Physical locations of this company

Registered office

Pelgrimsstraat 108

7700 Mouscron

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0688.592.112
VAT number: BE 0688.592.112
Registered office: Pelgrimsstraat 108, 7700 Mouscron
Names & denominations: DEFFONTAINE BIOLOGIE CLINIQUE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 18 January 2018
Peppol: Active · Active since 19 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗